Insider · CIK 0001814338

Nguyen Diem

Reports to the SEC for 3 companies · NEEDHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001814338

Forms 4 and 5

Insider transactions

34 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-23	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+32K sh	—	—	32,000
2026-06-05	VRCAVerrica Pharmaceuticals Inc. · Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2026-03-13	SIGASIGA TECHNOLOGIES INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+85K sh	—	—	185,796
2026-03-13	SIGASIGA TECHNOLOGIES INCF Tax Payment	Director, Chief Executive Officer	FTax Payment	−47K sh	$5.26	−$247K	138,767
2026-03-13	SIGASIGA TECHNOLOGIES INC · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−85K sh	—	—	170,092
2026-03-13	SIGASIGA TECHNOLOGIES INC · Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+272K sh	—	—	272,243
2026-01-27	SIGASIGA TECHNOLOGIES INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+55.9K sh	—	—	123,555
2026-01-27	SIGASIGA TECHNOLOGIES INCF Tax Payment	Director, Chief Executive Officer	FTax Payment	−22.8K sh	$6.82	−$156K	100,751
2026-01-27	SIGASIGA TECHNOLOGIES INC · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−55.9K sh	—	—	55,903
2025-06-17	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.2K sh	—	—	14,240
2025-06-05	VRCAVerrica Pharmaceuticals Inc. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2025-03-13	SIGASIGA TECHNOLOGIES INC · Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+255K sh	—	—	255,137
2025-01-27	SIGASIGA TECHNOLOGIES INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+55.9K sh	—	—	91,297
2025-01-27	SIGASIGA TECHNOLOGIES INCF Tax Payment	Director, Chief Executive Officer	FTax Payment	−23.6K sh	$6.34	−$150K	67,653
2025-01-27	SIGASIGA TECHNOLOGIES INC · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−55.9K sh	—	—	111,805
2024-10-25	SIGASIGA TECHNOLOGIES INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+59.3K sh	—	—	59,288
2024-10-25	SIGASIGA TECHNOLOGIES INCF Tax Payment	Director, Chief Executive Officer	FTax Payment	−23.9K sh	$6.77	−$162K	35,395
2024-10-25	SIGASIGA TECHNOLOGIES INC · Performance Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−59.3K sh	—	—	118,577
2024-06-26	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.2K sh	—	—	14,240
2024-06-06	VRCAVerrica Pharmaceuticals Inc. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2024-01-27	SIGASIGA TECHNOLOGIES INC · Stock Option (Right to buy)A Award	Director, Chief Executive Officer	AAward	+110K sh	—	—	109,606
2024-01-27	SIGASIGA TECHNOLOGIES INC · Stock Option (Right to buy)A Award	Director, Chief Executive Officer	AAward	+219K sh	—	—	219,212
2024-01-27	SIGASIGA TECHNOLOGIES INC · Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+168K sh	—	—	167,707
2024-01-27	SIGASIGA TECHNOLOGIES INC · Performance Stock UnitsA Award	Director, Chief Executive Officer	AAward	+178K sh	—	—	177,865
2023-06-28	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.2K sh	—	—	14,240
2023-06-08	VRCAVerrica Pharmaceuticals Inc. · Stock Option (right to buy)A Award	Director	AAward	+10.4K sh	—	—	10,384
2022-10-13	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.2K sh	—	—	14,240
2022-06-09	VRCAVerrica Pharmaceuticals Inc. · Stock Option (right to buy)A Award	Director	AAward	+10.4K sh	—	—	10,384
2021-07-29	CADLCandel Therapeutics, Inc.P Purchase	Director	PPurchase	+10K sh	$8.00	+$80K	10,000
2021-07-26	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+28.5K sh	—	—	28,480
2021-07-26	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+28.8K sh	—	—	28,840
2021-06-10	VRCAVerrica Pharmaceuticals Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,109 sh	—	—	8,109
2021-06-10	VRCAVerrica Pharmaceuticals Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,834 sh	—	—	5,834
2020-06-09	VRCAVerrica Pharmaceuticals Inc. · Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,502

Recent filings

Accepted (ET)
Jun 244
Nguyen Diem0001814338-26-000004
SEC(opens sec.gov)
Jun 94
Nguyen Diem0001814338-26-000002
SEC(opens sec.gov)
Mar 174
Nguyen Diem0001193125-26-110759
SEC(opens sec.gov)
Jan 284
Nguyen Diem0001193125-26-027202
SEC(opens sec.gov)
Jun 184
Nguyen Diem0000950170-25-087698
SEC(opens sec.gov)
Jun 94
Nguyen Diem0001415889-25-016288
SEC(opens sec.gov)
Mar 144
Nguyen Diem0000950170-25-039560
SEC(opens sec.gov)
Jan 294
Nguyen Diem0000950170-25-010569
SEC(opens sec.gov)
Oct 294
Nguyen Diem0000950170-24-118340
SEC(opens sec.gov)
Jun 274
Nguyen Diem0000950170-24-078174
SEC(opens sec.gov)
Jun 74
Nguyen Diem0001415889-24-015960
SEC(opens sec.gov)

Companies

Address

C/O CANDEL THERAPEUTICS, INC. 117 KENDRICK ST., SUITE 450

NEEDHAM, MA, 02494